Western Health Advantage - All plan years
Duobrii (halobetasol propion-tazarotene)
Drugs for the Skin : Drugs for the Skin
  • Quantity Limit: limit maximum 750 mL PER 30 day(s)
  • Prior Authorization: Diabetic Retinopathy, Macular Edema, Macular Edema Following Retinal Vein Occlusion (RVO), Neovascular (Wet) Age-Related Macular Degeneration (AMD):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 6 Month(s)
    Reauthorization Required: Yes

    Myopic Choroidal Neovascularization (mCNV):
    Documented Diagnosis: Yes
    Age Requirement: >= 18
    Duration: 3 Month(s)
    Reauthorization Required: Yes

<< Return | Back to top